Toby Maher is British Lung Foundation Chair in Respiratory Research and Professor of Interstitial Lung Disease at the National Heart and Lung Institute at Imperial College London, UK. He holds a prestigious National Institute of Health Research Clinician Scientist Fellowship and is also Director of Respiratory Research and a consultant physician at the Royal Brompton Hospital, London. His research interests include biomarker discovery, the lung microbiome and host immune response in the pathogenesis of IPF, and clinical trials in fibrotic lung disease. He has been actively involved in the running of over 45 trials in fibrotic lung disease.
Prof. Maher is an associate editor for the American Journal of Respiratory and Critical Care Medicine. He is on the editorial board of the European Respiratory Journal and European Respiratory Review as well as the International Advisory Board for Lancet Respiratory Medicine. He has authored over 200 papers and book chapters on IPF and ILD.